Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2017
|
Stephen J Hemsley Director |
SELL
Bona fide gift
|
Direct |
46,000
-1.48%
|
-
|
|
Dec 22
2017
|
David S Wichmann Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
24,000
-2.98%
|
-
|
|
Dec 21
2017
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
114,255
-12.43%
|
$25,364,610
$222.38 P/Share
|
|
Dec 21
2017
|
David S Wichmann Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
203,642
+18.13%
|
$6,720,186
$33.94 P/Share
|
|
Dec 15
2017
|
Larry C Renfro Vice Chmn, UHG and CEO, Optum |
SELL
Open market or private sale
|
Direct |
22,598
-11.57%
|
$4,994,158
$221.75 P/Share
|
|
Dec 14
2017
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-4.55%
|
$197,574
$221.25 P/Share
|
|
Dec 14
2017
|
Stephen J Hemsley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
797
-0.05%
|
$176,137
$221.25 P/Share
|
|
Dec 14
2017
|
Larry C Renfro Vice Chmn, UHG and CEO, Optum |
SELL
Payment of exercise price or tax liability
|
Direct |
574
-0.29%
|
$126,854
$221.25 P/Share
|
|
Dec 14
2017
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,822
-0.25%
|
$402,662
$221.25 P/Share
|
|
Dec 12
2017
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.1%
|
-
|
|
Dec 12
2017
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.0%
|
-
|
|
Dec 12
2017
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.34%
|
-
|
|
Dec 12
2017
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.3%
|
-
|
|
Dec 12
2017
|
Rodger A Lawson Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.25%
|
-
|
|
Dec 12
2017
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.7%
|
-
|
|
Dec 12
2017
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
142
+0.32%
|
-
|
|
Dec 12
2017
|
Kenneth Irwin Shine Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.34%
|
-
|
|
Dec 12
2017
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.12%
|
-
|
|
Dec 12
2017
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.7%
|
-
|
|
Dec 12
2017
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
447
+0.03%
|
-
|
|
Dec 12
2017
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.33%
|
-
|
|
Dec 12
2017
|
Larry C Renfro Vice Chmn, UHG and CEO, Optum |
BUY
Grant, award, or other acquisition
|
Direct |
122
+0.06%
|
-
|
|
Dec 12
2017
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.28%
|
-
|
|
Dec 12
2017
|
Marianne D Short EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59
+0.07%
|
-
|
|
Dec 12
2017
|
David S Wichmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
134
+0.02%
|
-
|
|
Dec 12
2017
|
D Ellen Wilson Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
52
+0.16%
|
-
|
|
Dec 12
2017
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
86
+0.14%
|
-
|
|
Dec 04
2017
|
Michele J Hooper Director |
SELL
Open market or private sale
|
Direct |
5,000
-13.52%
|
$1,110,000
$222.2 P/Share
|
|
Dec 04
2017
|
Michele J Hooper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.91%
|
$125,000
$25.08 P/Share
|
|
Nov 29
2017
|
Richard T Burke Director |
SELL
Bona fide gift
|
Direct |
10,000
-0.55%
|
-
|
|
Nov 29
2017
|
Gail R Wilensky |
SELL
Open market or private sale
|
Direct |
5,600
-4.62%
|
$1,248,800
$223.38 P/Share
|
|
Nov 29
2017
|
Gail R Wilensky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,600
+4.3%
|
$291,200
$52.38 P/Share
|
|
Nov 21
2017
|
Richard T Burke Director |
SELL
Bona fide gift
|
Direct |
10,000
-0.55%
|
-
|
|
Nov 14
2017
|
Kenneth Irwin Shine Director |
SELL
Open market or private sale
|
Direct |
457
-1.56%
|
$96,427
$211.03 P/Share
|
|
Nov 03
2017
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,853
-7.52%
|
$392,836
$212.87 P/Share
|
|
Oct 19
2017
|
Thomas E Roos Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
975
-3.81%
|
$199,875
$205.47 P/Share
|
|
Oct 02
2017
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.31%
|
-
|
|
Oct 02
2017
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.01%
|
-
|
|
Oct 02
2017
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
380
+24.34%
|
-
|
|
Oct 02
2017
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.69%
|
-
|
|
Oct 02
2017
|
Rodger A Lawson Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.8%
|
-
|
|
Oct 02
2017
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
140
+50.0%
|
-
|
|
Oct 02
2017
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
412
+0.93%
|
-
|
|
Oct 02
2017
|
Kenneth Irwin Shine Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.75%
|
-
|
|
Oct 02
2017
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
223
+0.2%
|
-
|
|
Oct 02
2017
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
140
+50.0%
|
-
|
|
Sep 25
2017
|
Richard T Burke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,090
+0.17%
|
$292,320
$48.02 P/Share
|
|
Sep 19
2017
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
84
+0.12%
|
-
|
|
Sep 19
2017
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
84
+0.0%
|
-
|
|
Sep 19
2017
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.5%
|
-
|